RPSAP13

Across TCGA pan-cancer cohorts, RPSAP13 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RPSAP13’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPSAP13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP13 is over-expressed in tumor.

LUAD, COAD, and LUSC are the cancer types where RPSAP13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.142	<.001	8	view →
COAD	All	II,III,IV	+0.119	<.001	7	view →
LUSC	Male	II,III,IV	+0.157	<.001	5	view →
HNSC	All	All	+0.053	.002	5	view →
BLCA	All	III,IV	+0.192	.006	4	view →
BRCA	All	All	+0.101	<.001	4	view →
STAD	Male	All	+0.132	.002	3	view →
READ	All	All	+0.120	<.001	2	view →
PRAD	All	All	+0.026	.009	2	view →
KIRP	All	II,III,IV	+0.057	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RPSAP13–LUAD

Open the LUAD breakdown →